Isolation of Human Ventricular Cardiomyocytes from Vibratome-Cut Myocardial Slices
May 10th, 2020
10.7K views
Presented is a protocol for the isolation of human and animal ventricular cardiomyocytes from vibratome-cut myocardial slices. High yields of calcium-tolerant cells (up to 200 cells/mg) can be obtained from small amounts of tissue (<50 mg). The protocol is applicable to myocardium exposed to cold ischemia for up to 36 h.
Overview
This protocol outlines the isolation of human and animal ventricular cardiomyocytes from vibratome-cut myocardial slices. It enables high yields of calcium-tolerant cells, facilitating research into cardiac disease mechanisms.
Key Study Components
Area of Science
- Cardiomyocyte isolation
- Cardiac physiology
- Electrophysiological analysis
Background
- Isolation of cardiomyocytes is crucial for studying heart function.
- Vibratome cutting allows for precise tissue slicing.
- Calcium-tolerant cells are essential for accurate experimental results.
- Research can be conducted on samples exposed to cold ischemia.
Purpose of Study
- To provide a reliable method for cardiomyocyte isolation.
- To enhance understanding of cardiac disease mechanisms.
- To facilitate electrophysiological and biochemical analyses.
Methods Used
- Preparation of cold cutting solution.
- Use of vibratome for tissue slicing.
- Isolation of myocytes from myocardial slices.
- Analysis of isolated cells for research purposes.
Main Results
- Up to 200 myocytes can be isolated per milligram of tissue.
- Protocol applicable to samples after transportation.
- High viability of isolated cells supports further analysis.
- Method allows for study of cardiomyocytes from ischemic conditions.
Conclusions
- The protocol provides a robust method for cardiomyocyte isolation.
- It supports research into cardiac diseases and their mechanisms.
- High yields of viable cells enhance experimental outcomes.
Frequently Asked Questions
What types of samples can be used for this protocol?
Both human and animal heart samples can be utilized.
How long can tissue samples be stored before processing?
Tissue samples can be exposed to cold ischemia for up to 36 hours.
What is the significance of calcium-tolerant cells?
Calcium-tolerant cells are crucial for accurate electrophysiological studies.
What equipment is necessary for this protocol?
A vibratome and a cooled tissue culture dish are required.
Can this method be applied to ischemic tissues?
Yes, the protocol is designed for tissues exposed to ischemia.
What are the potential risks when handling human tissue samples?
Human tissue samples are potentially infectious and should be handled with care.
Executive Industry Relevance
This protocol addresses a critical bottleneck in cardiac drug discovery by enabling reliable isolation of viable human ventricular cardiomyocytes from limited tissue samples, supporting translational validation of animal model findings. The method enhances predictive confidence in target validation by providing access to physiologically relevant human cells for mechanistic de-risking. It is particularly valuable for institutions without on-site cardiac surgery, expanding access to human tissue for preclinical research.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses in human cardiomyocytes, clarifying pathway relevance and reducing mechanistic ambiguity.
- Operational Value: Provides a reproducible source of rod-shaped, calcium-tolerant cardiomyocytes for functional assays.
- Strategic Value: Supports target de-risking by allowing verification of animal model findings in human cells before lead optimization.
Screening & Assay Development
- Scientific Value: Delivers high-yield, viable cardiomyocytes suitable for electrophysiological, structural, and biochemical analysis.
- Operational Value: Standardizes cell preparation from myocardial slices, improving assay consistency and scalability.
- Strategic Value: Enables reliable compound screening in human cells, increasing predictive confidence for cardiac safety and efficacy.
Translational & Preclinical Research
- Scientific Value: Maintains cellular excitability and contractility, supporting disease-relevant modeling of cardiac pathophysiology.
- Operational Value: Allows isolation from tissue stored up to 36 hours in cold cardioplegic solution, facilitating multi-site collaboration.
- Strategic Value: Bridges discovery and preclinical stages by providing translatable human cell data for go/no-go decisions.
Pipeline & Workflow Integration
The method fits within the early discovery continuum, supporting target validation through human cell-based assays and enabling lead identification via functional screening in disease-relevant systems.
- Discovery Biology: Supports hypothesis testing and pathway clarification by providing access to viable human ventricular cardiomyocytes.
- Screening: Enhances assay readiness through standardized isolation of rod-shaped myocytes with high viability and functional integrity.
- Analytics: Enables quantitative assessment via flow cytometry and functional readouts such as calcium transients and action potential duration.
- Translational Research: Connects animal model findings to human physiology through direct comparison in isolated cardiomyocytes.
- Enterprise Reuse: Establishes a reusable platform for cardiomyocyte isolation across projects, reducing dependency on variable tissue sources.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation by reducing species-specific translational gaps.
- Operational Value: Improves reproducibility and scalability of cardiomyocyte isolation from limited human tissue samples.
- Strategic Value: Enhances capital efficiency by enabling early de-risking of targets using human cell data.
- Portfolio Impact: Supports risk-adjusted prioritization of candidates based on human cardiomyocyte responses.
Implementation Considerations
- Requires expertise in tissue handling, vibratome operation, and enzymatic digestion protocols.
- Depends on access to a vibratome, temperature-controlled incubation systems, and standard cell culture equipment.
- Necessitates standardized protocols across teams to ensure consistency in slice thickness, enzyme exposure, and calcium reintroduction.
- Requires adaptation considerations for varying tissue quality, including fibrotic or ischemic samples.
- Limited by the availability of human myocardial specimens, though mitigated by tolerance to cold ischemia up to 36 hours.
Biopharma FAQs
Why does vibratome slicing improve cardiomyocyte yield compared to tissue chunks?
Vibratome-cut myocardial slices increase surface-to-volume ratio, enhancing enzyme access and significantly improving yields of rod-shaped cardiomyocytes (41.5% vs. 7.89% in rat, 45.0% vs. 6.87% in human) over tissue-chunk methods.
How does enzymatic isolation from slices support target validation in discovery?
Isolation yields viable, calcium-tolerant human cardiomyocytes suitable for functional assessment, enabling mechanistic de-risking by confirming target relevance in human cells.
What quantitative measurements enable assessment of isolation success?
Flow cytometry quantifies viable rod-shaped cardiomyocytes per milligram of tissue, with yields reaching 9–200 cells/mg in human myocardium, supporting reproducibility and assay standardization.
Why does tissue stability up to 36 hours matter for cross-functional collaboration?
The ability to isolate excitable cardiomyocytes from tissue stored in cold cardioplegic solution for up to 36 hours enables transport and use across sites without on-site surgery.
What analytical capabilities are needed to assess isolated cardiomyocyte quality?
Light microscopy verifies rod shape, cross striations, and membrane integrity, while electrophysiological and calcium transient measurements confirm excitability and contractility for downstream use.
